Vol. 44 No. 2 (2022): Experimental Oncology

View Vol. 44 No. 2 (2022): Experimental Oncology
DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2
Published: 26.05.2023

Editorial

Frontiers in oncology

Reviews

  • HUMAN MICROBIOTA AND BREAST CANCER

    Yu.V. Shvets, O.O. Lykhova, V.F. Chekhun
    95-106
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17855

Original contributions

  • SIGNIFICANCE OF ADC MEASUREMENTS AS RADIOLOGICAL MRI MARKER IN DETECTION OF METASTATIC LYMPH NODE INVOLVEMENT IN PATIENTS WITH PROSTATE CANCER

    Yu.O. Mytsyk, S.M. Pasichnyk, Yu.S. Kobilnyk, O.A. Borzhiievskyi, O.E. Lychkovskyy, P. Kowal, M. Pietrus, V.M. Matskevych, R.I. Dats, O.M. Blavatska, E.O. Stakhovsky, A.I. Gozhenko, A.Ts. Borzhiievskyi
    142-147
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17810

  • CHEMORESISTANCE RELATED TO HYPOXIA ADAPTATION IN MESOTHELIOMA CELLS FROM TUMOR SPHEROIDS

    D. Endoh, K. Ishii, K. Kohno, N. Virgona, Y. Miyakoshi, T. Yano, T. Ishida
    121-125
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.18045

  • TRANSCRIPTIONAL ANALYSIS OF ZINC-DEPENDENT HISTONE DEACETYLASES IN SEVERAL HUMAN CANCER CELLS

    Yan Li, Yefang Zou, Xiaoxue Chen, Bin He
    126-131
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17983

  • EXPRESSION OF miRNA AS PROGNOSTIC MARKERS OF RENAL CELL CARCINOMA COURSE

    Yu. Vitruk, T. Borikun, O. Rossylna, T. Zadvornyi, S. Semko, O. Voylenko, O. Stakhovsky, A. Shipko, E. Stakhovsky
    132-136
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17883

  • POLYAMINES AS NEW POTENTIAL BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PROSTATE CANCER AND ESTIMATION OF ITS AGGRESSIVENESS

    S.P. Zaletok, O.O. Klenov, V.V. Bentrad, M.P. Prylutskyi, Yu.V. Vitruk, E.O. Stakhovsky, A.V. Timoshenko
    148-154
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17758

  • ONCOLYTIC ACTIVITY OF HUMAN ORTHOPNEUMOVIRUS IN CANCER CELL LINES

    I.M. Aziz, R. Bhat, M.A. Farrag, F.N. Almajhdi
    113-120
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.18084

  • EXPRESSION OF CHEMOKINE (C-C MOTIF) RECEPTOR 7 IN PROSTATE CANCER TISSUE OF YOUNG PATIENTS AND IN METASTATIC CANCER CELLS

    R. Parra-Medina, C. Payán-Gómez, N.L. Acosta-Vega, S. Ramírez-Clavijo
    137-141
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.18025

  • EXPRESSION OF OSTEOPONTIN AND OSTEONECTIN IN BREAST AND PROSTATE CANCER CELLS WITH DIFFERENT SENSITIVITY TO DOXORUBICIN

    T. Zadvornyi, N. Lukianova, T. Borikun, S. Gogol, P. Virych, O. Lykhova, V. Chekhun
    107-112
    DOI: https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-2.17886

Short communications

Case report